MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 238 filers reported holding MYRIAD GENETICS INC in Q2 2019. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $6,000 | -14.3% | 500 | 0.0% | 0.00% | – |
| Q1 2020 | $7,000 | -50.0% | 500 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $14,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $14,000 | 0.0% | 500 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $14,000 | -17.6% | 500 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $17,000 | +325.0% | 500 | +400.0% | 0.00% | – |
| Q1 2016 | $4,000 | -97.3% | 100 | -97.5% | 0.00% | -100.0% |
| Q3 2015 | $150,000 | +10.3% | 4,000 | 0.0% | 0.01% | +20.0% |
| Q2 2015 | $136,000 | -4.2% | 4,000 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $142,000 | +39.2% | 4,000 | +33.3% | 0.01% | 0.0% |
| Q4 2014 | $102,000 | +32.5% | 3,000 | +50.0% | 0.01% | +66.7% |
| Q3 2014 | $77,000 | -1.3% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $78,000 | +14.7% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $68,000 | +209.1% | 2,000 | +88.7% | 0.00% | +200.0% |
| Q4 2013 | $22,000 | – | 1,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 6,635,000 | $106,425 | 3.51% |
| Glenview Capital Management | 3,783,982 | $60,695,071 | 1.37% |
| AMH Equity Ltd | 47,285 | $758,451 | 0.83% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,973,312 | $31,651,924 | 0.75% |
| EARNEST PARTNERS LLC | 3,473,281 | $55,711,427 | 0.32% |
| AIMZ Investment Advisors, LLC | 40,985 | $657,399 | 0.29% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 280,767 | $4,503,503 | 0.13% |
| Beverly Hills Private Wealth, LLC | 19,687 | $315,779 | 0.09% |
| Artisan Partners Limited Partnership | 2,537,147 | $40,695,838 | 0.07% |
| Jump Financial, LLC | 84,924 | $1,362,181 | 0.05% |